Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
6,039 total articles
Broadcom is rallying on AI infrastructure demand and still offers a favorable asymmetric trade: robust cash generation, double-digit ROE, and rising technical momentum justify a tactical long. Entry at current levels, tight stop, and ambitious target capture continued multiple expansion plus business growth tied to hyperscaler AI spend.
Bombardier (BDRAF) has ripped higher today to $211.30, clearing key moving averages and putting momentum indicators into bullish territory. Thin OTC liquidity, periodic spikes in short interest and the recent surge in price create a path where further re-rating and corporate actions aimed at returning capital become more probable. This note lays ou…
DraftKings (DKNG) is a market leader in digital sports wagering and casino, but valuation and capital structure no longer match the business profile. With EV of roughly $12.3B, a high EV/EBITDA of 47.4x and a current ratio under 1.0, the stock looks exposed to downside if growth slows or regulatory tailwinds fade. This trade idea proposes a tactica…
Wayfair has pulled back after a blistering 2025-2026 run. With improving margins, positive free cash flow of $464M and a valuation below 1x price-to-sales, this dip looks like a tactical buying opportunity for traders who can stomach volatility. I outline a clear entry at $64.00, a stop at $58.00 and a target of $95.00 over a mid-term 45 trading da…
Townsquare Media (TSQ) is a small-cap, community-focused media company whose digital transformation is now producing recurring revenue and strategic partnerships. With digital above 50% of revenue, a recent alliance with Kroenke Sports & Entertainment, a market cap near $111M and a double-digit yield, TSQ offers an asymmetric mid-term trade: income…
Brown-Forman's collapse of merger talks with Pernod Ricard and a competing $32 cash bid from Sazerac left the stock without a clear path to a takeover premium. Fundamentals show solid free cash flow but limited upward catalysts, while technical momentum and heavy short activity point to a mid-term pullback. This trade idea sells BF.B at $25.80 with…
Bandwidth (BAND) is ripping higher today on heavy volume as the market begins to reward improving enterprise adoption and cash flow. The setup is a tactical swing trade: buy into strength at the market, protect with a tight stop below recent intraday lows, and target a materially higher multiple as adoption and partnership contribution become visib…
Eagle Materials (EXP) looks ready for an upgrade. Record revenue, strong free cash flow and healthy returns combine with attractive earnings multiple and improving technicals. This trade idea outlines a mid‑term long with clear entry at $205.00, stop at $195.00 and a $250.00 target over the next 45 trading days.
Royal Caribbean (RCL) looks set to keep recovering its pricing power despite near-term oil volatility. The company trades at a reasonable P/E (~16x) with strong ROE (42.5%) and positive free cash flow. We present a mid-term trade: entry $265.00, target $320.00, stop $242.00, horizon mid term (45 trading days).
Amazon's valuation already prices it as a cash-generative tech platform, but accelerating AI adoption across enterprises - and clear signs AWS can convert that demand into revenue - make a tactical long attractive. Entry at $265, target $320, stop $245; horizon: long term (180 trading days).
eBay looks like a constructive buy here: the company combines high returns on equity, steady free cash flow generation and shareholder-friendly buybacks with a refreshed growth runway (Depop acquisition and focus on collectibles). At roughly $104 per share, the stock trades at mid-20s P/E and an EV/EBITDA below 19, offering a favorable risk-reward …
Zenas BioPharma is a high-conviction long because management has secured new financing, is preparing a BLA filing for obexelimab, and expects Phase 2 lupus data by year-end 2026. The market has punished the stock after a disappointing IgG4-RD Phase 3 readout, leaving upside if obexelimab shows meaningful activity in SLE or if the FDA engagement aro…
Nuvalent is a clinical-stage precision oncology company with two lead kinase programs that have near-term regulatory and pivotal catalysts in 2026. The stock trades at about $99.35 with a market cap near $7.85B and roughly $2.87B in cash on the balance sheet. This trade idea is a directional long into upcoming FDA decisions and program readouts, wi…
Meta beat Q1 expectations with 33% revenue growth to $56.31B and sharply higher EPS, yet shares plunged after management raised 2026 capex to $125-145B. That capex is largely AI infrastructure spending that should expand long-term TAM and protect margins vs. competitors. This trade idea buys the selloff with a clear entry, stop and target aligned t…
Cullinan Therapeutics is a clinical-stage oncology and immuno-oncology company trading at roughly $790M market value while sitting on a large cash position. Positive pivotal data in its zipalertinib program and multiple clinical readouts set up a potential 2027 FDA catalyst. For traders willing to accept clinical binary risk, a mid-term long (45 tr…
Svenska Handelsbanken has the balance-sheet profile and business mix to weather renewed macro volatility. This trade idea recommends a long position with a clearly defined entry at $9.00, a stop at $7.80 and a primary target of $11.25 over a 180-trading-day horizon, aiming to capture a re-rating tied to stable profitability, steady dividend support…
QXO recently agreed to buy TopBuild for $17 billion, creating a much larger building-products distributor. The market punished QXO shares on dilution and leverage concerns, but the combined company will generate roughly $18 billion in revenue and target $300 million in synergies by 2030. With a market cap near $14.36B and free cash flow of $183.2M,…
Solid Power is showing incremental progress toward commercializing solid-state EV cells. Balance-sheet liquidity, a design that targets factory compatibility, and improving market sentiment create a tactical buying opportunity. This trade lays out an entry at $3.47, a $5.25 target and a $2.70 stop over a mid-term (45 trading days) horizon.
Eli Lilly's Q1 performance and the retatrutide clinical headline put the company in a class of its own. The stock is trading at $931.64 with a market cap near $880B, rich multiples but justified by blockbuster growth prospects and strong cash generation. This is a position trade: buy at market, stop at $870, target $1,100 over the next 180 trading …
FTAI Aviation ($FTAI) is firing on multiple cylinders: a growing engine leasing and MRO footprint, an expanding feedstock pipeline from recent Air France deals, and promising unit-conversion growth through FTAI Power and data-center partnerships. The stock is richly valued, but current upside is supported by concrete business drivers. We lay out a …
Anika Therapeutics ($ANIK) has pulled back from recent highs after a clinical setback and related investor investigations. The stock is trading at $12.46 with a market cap of roughly $166M and an enterprise value near $147M, while free cash flow remains positive. Technicals show oversold momentum and elevated short interest, creating a favorable ri…
Carlyle (CG) looks like a re-rating candidate trading near $49.60 with a market cap around $17-18 billion, $1.48 billion in trailing free cash flow and a conservative balance sheet (debt/equity ~0.52). Recent deal activity - a planned majority purchase of MAI (03/31/2026) and a conditional Lukoil asset bid (01/31/2026) - supports an earnings/AUM re…
CoreWeave (CRWV) has been repriced by headline-driven volatility even as fundamentals and capacity expansion point to sustained upside. Market cap sits near $62.4B while the company scales GPU capacity and consensus growth trajectories remain aggressive. This trade targets a rebound to $155 over the next 45 trading days with a tight structural stop…
Twenty One Capital (XXI) is a newly formed Bitcoin treasury vehicle whose stock has drawn regulatory scrutiny and rising short activity. With a $5.15B market cap, elevated short volume and a recent shareholder litigation probe, we lay out a mid-term (45 trading days) short trade: entry $7.90, target $5.80, stop $10.50. The trade is high risk but of…
BlackSky (BKSY) is trading at $34 after a run-up driven by government awards and the rollout of higher-resolution Gen-3 satellites. The business is unprofitable today, but near-term revenue visibility has improved through a $99M multi-year IDIQ and a nearly $30M one-year Assured subscription. This trade idea outlines a long entry at $34 with a $42.…
